ARCHIVES

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 38 | October 6, 1989

Download PDF Visit The Full Archive

Related Articles

Dinner To Raise Funds For NIH Children’s Inn

March 31, 1989

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

Symposium Planned On Hyperthermia

April 23, 1976

HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says

November 11, 1994

In Brief: Senate Subcommittee Adds $100 Million For NCI Over House Bill, No Further Action Until Sept.

August 8, 1975

Exercisers May Have Higher Breast Cancer Survival

October 27, 2006